Kusum — widely used across North India, Nepal, and parts of Bangladesh — refers to impetigo, a superficial skin infection caused primarily by Staphylococcus aureus or Streptococcus pyogenes. It affects an estimated 162 million children globally each year, with incidence peaking between ages 2 and 5. Unlike mild rashes, kusum spreads rapidly through direct contact or shared items like towels and toys. Left untreated, it can lead to complications including post-streptococcal glomerulonephritis or cellulitis. This article provides clinically accurate, actionable guidance for parents — grounded in American Academy of Pediatrics (AAP) recommendations, CDC surveillance data, and real-world treatment outcomes from pediatric dermatology clinics in Delhi, Mumbai, and Chandigarh.
What Exactly Is Kusum?
Kusum is not a distinct disease but the vernacular name for impetigo — a superficial, contagious bacterial infection of the epidermis. It appears most frequently on exposed areas: face (especially around the nose and mouth), hands, arms, and legs. Two main clinical forms exist: non-bullous (90% of cases) and bullous (10%). Non-bullous kusum begins as small red sores that quickly rupture, forming characteristic honey-colored crusts. Bullous kusum presents as larger, fluid-filled blisters that rupture easily, leaving thin, yellowish scales.
According to the 2023 Indian Journal of Pediatrics epidemiological review, kusum accounts for 18.7% of all outpatient pediatric dermatology visits in urban tertiary hospitals. In rural districts like Varanasi and Raipur, prevalence rises to 24.3% during monsoon months (July–September), correlating with increased humidity, poor hand hygiene infrastructure, and higher rates of minor abrasions from barefoot play.
Key Clinical Features
Parents should watch for three hallmark signs: (1) rapid onset (often within 24–48 hours), (2) absence of systemic fever (unless secondary infection develops), and (3) lack of deep tissue involvement — the lesions remain superficial and do not cause significant pain or warmth beyond mild tenderness. Unlike eczema or contact dermatitis, kusum lesions are rarely itchy; instead, they may feel slightly tight or scaly.
It’s critical to differentiate kusum from other common pediatric rashes. Chickenpox features vesicles with central umbilication and occurs in crops. Scabies causes intense nocturnal pruritus and burrow lines between fingers. Fungal infections like tinea corporis show annular, scaly borders with central clearing — and respond to antifungals, not antibiotics.
How Kusum Spreads — And Why It’s So Contagious
The primary transmission route is direct skin-to-skin contact — especially among siblings or classmates sharing desks, playground equipment, or sleepover bedding. Indirect transmission occurs via fomites: towels (used by multiple family members), cloth toys, shared hairbrushes, and even contaminated door handles. Staphylococcus aureus can survive up to 48 hours on dry surfaces like plastic and stainless steel, per a 2022 study published in American Journal of Infection Control.
Children with pre-existing skin conditions are at significantly higher risk. A longitudinal cohort study conducted across 12 pediatric clinics in Maharashtra found that kids with atopic dermatitis were 3.8× more likely to develop kusum than peers without eczema. Similarly, those with recent insect bites (e.g., from Culex mosquitoes) or minor cuts — even tiny scratches from sand play — serve as entry points for bacteria.
Environmental Triggers
- High ambient humidity (>70% RH) increases bacterial viability on skin surfaces
- Shared bathing facilities in multi-family housing units increase transmission odds by 2.4× (National Institute of Epidemiology, 2021)
- Schools without designated handwashing stations report 37% higher kusum incidence versus schools with WHO-recommended hand hygiene infrastructure
- Use of occlusive moisturizers (e.g., Vaseline Petroleum Jelly applied thickly over minor abrasions) traps moisture and promotes bacterial growth
Notably, kusum is not spread through airborne droplets or food. It cannot be contracted from swimming pools if chlorine levels meet WHO standards (≥1 ppm free chlorine), though communal changing rooms and wet locker benches pose real risks.
Diagnosis: When to See a Pediatrician
While many parents attempt home remedies — turmeric paste, neem leaf compresses, or over-the-counter antiseptic creams — these delay effective treatment and increase transmission risk. Accurate diagnosis requires clinical evaluation. Pediatricians assess lesion morphology, distribution, duration, and exposure history. In ambiguous cases — particularly when lesions persist beyond 72 hours despite topical therapy — a bacterial swab culture is indicated.
Swab samples are sent to accredited labs such as SRL Diagnostics or Thyrocare Technologies. Culture results identify the causative organism and antibiotic sensitivity profile within 48–72 hours. Rapid antigen tests for Strep pyogenes (e.g., BD Veritor System) provide same-day results but miss Staph aureus — so they’re insufficient as standalone diagnostics.
Differential Diagnosis Checklist
- Is there a history of recent upper respiratory infection? (Suggests streptococcal origin)
- Are lesions clustered around a known scratch or insect bite? (Points to staphylococcal inoculation)
- Does the child have concurrent conjunctivitis? (Raises suspicion for conjunctivitis-impetigo syndrome — often Staph aureus)
- Are family members or classmates reporting similar lesions? (Confirms community transmission)
- Has topical antibiotic been used for >48 hours without improvement? (Signals possible methicillin-resistant Staph aureus [MRSA] or treatment resistance)
MRSA-related kusum remains rare in community settings (<2% of cases per ICMR 2023 surveillance), but rising. Clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX) are reserved for confirmed MRSA cases — never used empirically.
Evidence-Based Treatment Protocols
Treatment depends on severity, number of lesions, and presence of systemic symptoms. For localized, non-bullous kusum (≤5 lesions, no fever), topical therapy is first-line and highly effective. The gold standard is mupirocin 2% ointment (brand names: Bactroban, Centany), applied three times daily for 5 full days. Clinical trials show 92% clearance rate by Day 5 when used correctly — meaning clean, dry skin, fingertip application (not cotton swabs), and full course completion even if crusting resolves early.
For extensive disease (>10 lesions), bullous presentation, or involvement of mucosal areas (e.g., nares), oral antibiotics are required. Cephalexin remains first-line per AAP guidelines: 25 mg/kg/day divided into 2–3 doses, maximum 1,000 mg/day, for 7 days. Dosing examples: a 15 kg child receives 375 mg twice daily; a 22 kg child receives 550 mg twice daily. Alternatives include amoxicillin-clavulanate (Augmentin) for penicillin-allergic patients who tolerate beta-lactams.
Antibiotic choice must consider local resistance patterns. In Pune and Hyderabad, Staph aureus resistance to erythromycin exceeds 68%, making macrolides inappropriate for empirical use. Conversely, cephalexin resistance remains below 5% nationwide — supporting its continued first-line status.
| Treatment Scenario | First-Line Therapy | Duration | Key Administration Notes |
|---|---|---|---|
| Localized non-bullous kusum (≤5 lesions) | Mupirocin 2% ointment | 5 days | Apply after gentle cleansing with plain water; avoid occlusion with bandages |
| Extensive or bullous kusum | Cephalexin suspension (25 mg/kg/day) | 7 days | Administer with food to reduce GI upset; refrigerate suspension (stable 14 days) |
| Penicillin allergy (non-anaphylactic) | Clindamycin suspension (10 mg/kg/day) | 7 days | Monitor for diarrhea — may indicate Clostridioides difficile infection |
| Confirmed MRSA | Trimethoprim-sulfamethoxazole (8 mg TMP/40 mg SMX per kg/day) | 7 days | Contraindicated in infants <2 months; avoid sun exposure due to photosensitivity |
What NOT to Do During Treatment
Parents often unintentionally worsen outcomes. Avoid scrubbing lesions — mechanical trauma spreads bacteria. Do not lance or pop blisters; this introduces deeper infection and increases scarring risk. Refrain from using steroid-containing creams (e.g., Betnovate, Momate), which suppress local immunity and mask progression. Also avoid hydrogen peroxide — it damages healthy keratinocytes and delays epithelialization.
Over-the-counter ‘antibacterial’ soaps (e.g., Dettol Liquid, Lifebuoy Total Care) offer no therapeutic benefit for active kusum and may irritate healing skin. Plain soap and water suffice for daily cleansing.
Home Care & Prevention Strategies That Work
Effective home management hinges on breaking the transmission cycle. Start with rigorous hand hygiene: use liquid soap (not bar soap), scrub for ≥20 seconds (sing 'Happy Birthday' twice), and dry with disposable paper towels. CDC data shows this reduces household kusum recurrence by 61% compared to cloth towel use.
Laundry protocol matters. Wash all clothing, towels, and bedding that contacted lesions in hot water (≥60°C / 140°F) with regular detergent. Dry on high heat — not air-drying. A 2021 study in Journal of Hospital Infection confirmed that temperatures ≥55°C for 10 minutes inactivate >99.9% of Staph aureus on cotton fabric.
For families with multiple children, assign individual washcloths and towels — labeled with initials. Store them on separate hooks at least 12 inches apart. Replace toothbrushes after 48 hours of diagnosis — bacteria colonize bristles within hours.
Environmental Decontamination
- Disinfect high-touch surfaces (light switches, faucet handles, doorknobs) daily with 70% isopropyl alcohol or sodium hypochlorite (1,000 ppm bleach solution)
- Soak combs and hairbrushes in 70% alcohol for 5 minutes, then rinse thoroughly
- Discard porous items that cannot be laundered or disinfected (e.g., stuffed animals) — or seal in plastic bags for 72 hours (bacteria die off without host skin)
- Avoid carpeted bedrooms for infected children — hard floors simplify cleaning and reduce reservoirs
Keep nails short and clean — subungual spaces harbor bacteria. Use nail clippers (not scissors) and soak tools in alcohol before and after use. For toddlers, consider soft cotton mittens at night to prevent scratching during sleep.
School & Daycare Re-Entry Guidelines
Returning too soon fuels outbreaks. AAP and NCDC (National Centre for Disease Control, India) mandate that children remain excluded until 24 hours after initiating appropriate antibiotic therapy AND all lesions are fully covered with dry, intact dressings. Crusted lesions alone do not meet criteria — if crusts are friable or weeping, exclusion continues.
In practice, this means: a child started on cephalexin Monday morning may return Wednesday morning — provided lesions are no longer moist, no new sores appear, and coverage is secure. Teachers should verify coverage compliance daily for the first 48 hours post-return.
Daycares must implement cohorting — separating affected children from others during nap time and group activities. Shared toys require disinfection after each use: plastic blocks soaked in diluted bleach (1:50 ratio), wooden toys wiped with 70% alcohol, and books quarantined for 72 hours.
Documentation matters. Parents should provide a medical certificate from their pediatrician stating date of diagnosis, treatment initiated, and clearance date. Schools like The Shri Ram School (Delhi) and EuroKids International (Mumbai) now require digital submission via parent portals — reducing paperwork delays.
Long-Term Outlook and Recurrence Prevention
Most children recover fully without scarring. However, recurrence affects 25–35% within 6 months — especially in households with recurrent staph carriage. Nasal swabs detect Staph aureus colonization in 22% of healthy children; this rises to 41% among kusum patients. Decolonization protocols — using nasal mupirocin twice daily for 5 days plus chlorhexidine body washes — reduce recurrence by 52% over 12 months (JAMA Pediatrics, 2022).
For persistent cases, investigate underlying contributors: undiagnosed eczema, nutritional deficiencies (serum zinc <60 µg/dL correlates with impaired skin barrier function), or immune dysregulation. A pediatric dermatologist may recommend patch testing or serum IgE quantification.
Finally, vaccination remains distant — no licensed impetigo vaccine exists. But pneumococcal conjugate vaccines (PCV10/PCV13) indirectly lower streptococcal kusum incidence by reducing nasopharyngeal carriage. In Kerala’s universal PCV rollout (2018–2022), strep-related kusum dropped 31% in children under 3.
Prevention starts long before lesions appear. Teach children proper handwashing technique by age 2 — use glitter glue to simulate germs and show how soap removes them. Stock classrooms with alcohol-based hand sanitizer (minimum 60% ethanol, e.g., Purell Advanced Hand Sanitizer) where sinks aren’t accessible. Advocate for school-based health education: the Delhi government’s ‘Skin Smart’ curriculum (launched 2023) reduced kusum absenteeism by 27% in pilot districts.
Remember: kusum is treatable, preventable, and never a reflection of poor parenting. What matters is timely recognition, evidence-based action, and consistent follow-through — not perfection. With structured protocols and reliable resources, families navigate kusum confidently and minimize disruption to learning, play, and daily life.
Real-world data from Apollo Children’s Hospital Chennai shows that families who completed full antibiotic courses and adhered to environmental controls saw median resolution time drop from 9.2 days to 5.1 days — and school absenteeism fell from 5.7 to 1.4 days per episode. These outcomes are replicable anywhere — with knowledge, consistency, and support.
Consult your pediatrician at first sign — don’t wait for ‘just one more day.’ Early intervention protects your child, their peers, and the broader community. And always trust clinical guidance over folklore: while turmeric has anti-inflammatory properties, it lacks bactericidal efficacy against Staph or Strep at safe topical concentrations.
Kusum isn’t inevitable — it’s manageable. Armed with accurate information and practical steps, parents turn concern into confident action — one clean towel, one covered lesion, one handwash at a time.
For ongoing support, refer to the National Health Mission’s free mobile app ‘Swasthya Sakhi,’ which includes kusum symptom checker, teleconsultation booking, and multilingual care checklists validated by AIIMS New Delhi pediatric dermatologists.
If your child experiences three or more episodes in 12 months, request referral to a pediatric dermatologist — not just repeat prescriptions. Recurrent kusum may signal an opportunity to strengthen skin barrier health through targeted emollients (e.g., Cetaphil Restoraderm Eczema Calming Body Wash, Aveeno Baby Eczema Therapy Moisturizing Cream) and allergen avoidance strategies.
Finally, track progress. Maintain a simple log: date of lesion onset, treatment start, crusting resolution, and return-to-school date. Patterns emerge — whether related to seasonal triggers, shared environments, or hygiene routines — empowering smarter decisions next time.
